Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
theophyllin vandfri 90 mg/150 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
theophyllin 300 mg vandfri tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
Theophylline anhydrous 100 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
Product containing precisely theophylline anhydrous 200 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
Theophylline anhydrous 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
Theophylline anhydrous 400 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
Product containing precisely theophylline anhydrous 75 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
Product containing precisely theophylline anhydrous 50 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
theophyllin 450 mg vandfri tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
Product containing precisely theophylline anhydrous 125 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
Theophylline anhydrous 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
Theophylline anhydrous 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
guaifenesin 90 mg+ theophyllin, vandfri 150 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
kaliumjodid 130 mg + teofyllin 80 mg vandfri eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
theophyllin 100 mg vandfri tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
theophyllin 600 mg vandfri tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
Theophylline anhydrous 100 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Theophylline anhydrous 100 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline anhydrous 200 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline anhydrous 200 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Theophylline anhydrous 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Theophylline anhydrous 300 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Theophylline anhydrous 400 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Theophylline anhydrous 400 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Theophylline anhydrous 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Theophylline anhydrous 400 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline anhydrous 75 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline anhydrous 75 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline anhydrous 50 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline anhydrous 50 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline anhydrous 125 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline anhydrous 125 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Theophylline anhydrous 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Theophylline anhydrous 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Theophylline, anhydrous 100mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
Theophylline anhydrous 450mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
Theophylline anhydrous 300mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
Theophylline, anhydrous 600mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Theophylline anhydrous |
Inferred relationship |
Some |
|
Product containing precisely theophylline anhydrous 125 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Theophylline anhydrous 100 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline anhydrous 200 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Theophylline anhydrous 300 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Theophylline anhydrous 400 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Theophylline anhydrous 400 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline anhydrous 75 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Product containing precisely theophylline anhydrous 50 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Theophylline anhydrous 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Product containing precisely etofylline 84.7 milligram/1 milliliter and theophylline anhydrous 25.3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Product containing precisely etofylline 84.7 milligram/1 milliliter and theophylline anhydrous 25.3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Etofylline 77 mg and theophylline anhydrous 23 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |
Etofylline 77 mg and theophylline anhydrous 23 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Theophylline anhydrous |
Inferred relationship |
Some |
1 |